Document is current
Any future updates will be listed below
-
Authors
Janorschke, Christian
Popescu, Sorin S.
Osburg, Jonas
Lu, Xinyu
Xie, Jingyang
Yaman, Engin
Marquetand, Christoph
Blanck, Oliver
Alessandrini, Hannes
Schweikard, Achim
Tilz, Roland R.
-
Funding
Funding for this research was provided by:
Universität zu Lübeck
- License Information
-
More Information
Article History
Received: 13 January 2025
Accepted: 20 August 2025
First Online: 5 September 2025
Declarations
:
: CJ, JX, XL, AS and OB have received funding from EU-Horizon-2020 Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary (STOPSTORM) consortium project (Grant Agreement No. 945119) outside of the presented work. RRT is a consultant for Boston Scientific, Philips, Medtronic Biosense Webster, Abbott Medical, he received speaker’s honoraria from Boston Scientific, Biotronik, Biosense Webster, Abbott Medical, Lifetech, Pfizer and research grants from Abbott, Biotronik, Medtronic, Biosense Webster, Lifetech, all outside of the presented work. He also received travel grants from Abbott, Biosense Webster, Boston Scientific, Medtronic and Philips outside of the presented work. SSP received travel grants and congress grants from Lifetech and an educational grant and speaker grant from Abbott Medical outside of the presented work. All other authors declare no Conflict of interest.
: The MATRIX-VT study has been submitted to and approved by the ethics committee of the University of Lübeck (study number 2023-498_1).
